Technology & Innovation
-
International Conference on Artificial Intelligence (Al), Privacy, and Governance
ConferenceNov 30–Dec 2, 2024
This conference aims to explore important issues of economics of AI, good governance, humanization of AI technologies, privacy, considerations of creative thinking and imagination, and take a comprehensive look at the challenges and opportunities of AI technologies.
-
Musk and Tesla: Corporate Compensation, Financialization, and the Problem of Strategic Control
Sep 13, 2024
From the perspective of innovative enterprise, we ask how Musk might abuse his power of strategic control—and what that would mean for corporate governance reform.
-
Working Paper
Tesla as a Global Competitor: Strategic Control in the EV Transition
Sep 2024
As the “Technoking” of Tesla strategizes to maintain his control over the company’s decision-making, anyone concerned with the role that Tesla will play in the evolving EV transition should be asking how CEO Musk might use, or abuse, his powerful position.
-
Forget the Posturing – The Inflation Reduction Act May Work Better Than Many Expected
Aug 16, 2024
The IRA has the potential to rectify the imbalance between public benefit and private incentives
-
America Needs Intel Economically and Politically—But Is It Too Late?
Aug 12, 2024
With Pat Gelsinger at the helm, Intel’s fate will be decided by whether it can revive its innovation-driven legacy or remain a cautionary tale of financial mismanagement.
-
CrowdStrike Lessons: Liability Shields Fuel Risky Practices, Expert Warns
Jul 30, 2024
Cybersecurity expert Muayyad Al-Chalabi assesses CrowdStrike’s update failure and its broader implications for cybersecurity in a discussion with Lynn Parramore.
-
Crying Wolf: Why Negotiating Lower Drug Prices Will Not Harm Pharmaceutical Innovation
Jul 22, 2024
Increasing evidence that the IRA is probably not harming pharmaceutical innovation.
-
Working Paper
Implications of the Inflation Reduction Act for the Biotechnology Industry
Jul 2024
Sensitivity of investment and valuation to drug price indices and market conditions
-
How Do Tech Innovations Really Spread? New Evidence
Jul 11, 2024
New technologies appear to yield long-lasting benefits for the pioneer locations where they were originally developed.
-
Working Paper
The Diffusion of New Technologies
Jul 2024
The concentration of innovation in a handful of urban centers engenders large and persistent regional disparities in economic opportunity.
-
Musk and Tesla: Compensation or Control?
Jun 18, 2024
The $48 Billion Stock-Option Package and its Implications for the EV Transition
-
Antitrust Policy and Artificial Intelligence: Some Neglected Issues
Jun 10, 2024
An ensemble of mechanisms enables cloud hegemons (Microsoft, Google, Amazon) to plan the whole AI knowledge and innovation network by weaponizing interdependence in networks.
-
Experts: Negotiating Big Pharma's Prices Won't Stifle Innovation—They Don't Use the Money to Innovate!
Mar 14, 2024
Industry lobbyists vehemently oppose Medicare drug price negotiations. However, physician-scientist Fred Ledley and economist William Lazonick debunk their arguments.
-
LEPC VI: Ideas for Building the Future
ConferenceFeb 16–18, 2024
India: Climate Change, Technology, and Growth
-
How GM’s $10-Billion Buyback May Ice Its EV Transition
Dec 18, 2023
Reindustrialization vs Financialization